Forasma
Composition :
Eact tablet FORASMA® contains Terbutaline sulfate 2.5 mg
Eact 5 ml (1 measuring spoon) syrup FORASMA® contains Terbutaline sulfate 1.25 mg
Pharmacology :
- Terbutaline Sulfate is a selective amino sympatomimetic stimulant β2 receptor and causes relaxation of the bronchial and uterine muscle
- Terbutaline Sulfate also accelerates cilia movement and increases sticky mucus transport
- Effects of therapy usually occur after 50 minutes of oral administration and maximum at 120-180 minutes
Indication :
To relieve bronchi spasm in chronic respiratory diseases such as bronchial asthma, chronic bronchitis and emphysema
Dosage :
Tablet :
- Adult: 1-2 tablet, 3 times daily
- Patients who sensitive to amino sympatomimetic recommended initial dose of 1 tablet, 3 times daily, if bronchodilatation effect is not enough doses can be added
- Children: 1 tablet, 3 times daily
Syrup :
- Adult: 2-3 measuring spoons (10-15 mL), 3 times daily
- Children (12-15 years old): 1-2 measuring spoons (5-10 mL), 3 times daily
Presentation and Registration Number :
FORASMA® Tablet Box, 5 strips @ 10 tablets; DKL9608006210A1
FORASMA® Syrup Box, Bottle @ 60 ml; DKL9608006337A1
ON MEDICAL PRESCRIPTION ONLY
Categorised in:
This post was written by admin